Research Notes on Cosmegen Lyovac
Fast Facts:
- Can only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.2
- Used off-label to treat conditions such as Kaposi's sarcoma and osteosarcoma.3
- Common side effects include an allergic reaction, severe nausea, vomiting, and diarrhea.1
- Can cause liver damage and infertility.4
What is Cosmegen Lyovac?
- NetDoctor UK: Cosmegen Lyovac: How Does It Work?
- Cancerbackup: Dactinomycin (Cosmegen Lyovac)
- American Cancer Society: Dactinomycin
- American Society of Health-System Pharmacists (via MedlinePlus): Drug Information: Dactinomycin
- Cancer Research UK: Dactinomycin (Actinomycin D): What Dactinomycin Is
- Micromedex (via Mayo Clinic): Dactinomycin (Intravenous Route): Description
Sponsored Links
Company Information on Cosmegen Lyovac
- Merck & Co., Inc.: Official Site
- Wikipedia: Merck & Co., Inc.
- The New York Times Business: Merck & Company
Research Notes References
- ↑ 1.0 1.1 NetDoctor UK: Cosmegen Lyovac: How Does It Work?
- ↑ Cancerbackup: Dactinomycin (Cosmegen Lyovac)
- ↑ Micromedex (via Mayo Clinic): Dactinomycin (Intravenous Route): Description
- ↑ Cancer Research UK: Dactinomycin (Actinomycin D)
User Recommended Links for Cosmegen Lyovac
Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.
About this WisdomCard
- Contributor: Kricel Abreu
- Reviewer: Nicole Kinsey
- Supervised by: The OrganizedWisdom Physician Review Team
- Last update: Oct. 1, 2008
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic. In addition to filtering out spam and bad links, WisdomCards highlight tips and warnings, such as:
- Guide Favorite
- Guide Warning
- Scroll down to reach relevant content
- Video
- In Memoriam
Help improve this WisdomCard by suggesting great links.
RSS:
